Just a year ago, the GenAI buzz in pharma felt like the start of a gold rush. Leaders greenlit pilots. Teams spun up proof-of ...

The protein expression market is primarily driven by the increasing prevalence of chronic diseases, which in turn fuels greater demand for biopharmaceuticals, including monoclonal antibodies and ...